基本信息
浏览量:1
职业迁徙
个人简介
As a doctor working in the area of adult sleep and respiratory medicine in Queen's Medical Centre, Nottingham, I see first-hand many of the short-comings of some of our current drugs. For some medical conditions, we just do not have the right drugs. For other conditions the side-effects of our existing drugs cause problems for all, or some, of the people who take them. My research interests are therefore two-fold. Firstly, I am interested in the molecular pharmacology of GPCRs. These are the specialised docking sites on the outside of cells where certain hormones act (e.g. adrenaline), and where some drugs act (e.g. β-blockers for heart disease, and the blue inhalers used for asthma). My research is aimed at detailed scientific understanding of how these hormones and drugs interact with receptors to cause changes in the cell behaviour, and ultimately clinical benefit. Secondly, I combine my clinical and pharmacology knowledge to understand how clinical drugs act, why side effects occur, to help discover molecules without these side effects that have potential to become better future drugs, and to identify novel drugs for medical conditions with few treatment options. My ultimate aim is to improve clinical drug treatments for patients.
研究兴趣
论文共 117 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
British Journal of Pharmacologyno. S2 (2023): S23-S144
Jacopo Tricomi, Luca Landini, Valentina Nieddu,Ugo Cavallaro,Jillian G Baker,Athanasios Papakyriakou,Barbara Richichi
BRITISH JOURNAL OF PHARMACOLOGY (2023): S23-S144
Jillian G. Baker, Poornima Balaji,Richard A. Bond,David B. Bylund,Douglas C. Eikenburg,Robert M. Graham,J. Paul Hieble, Rebecca Hills,Martin C. Michel,Kenneth P. Minneman,Sergio Parra,Dianne M. Perez,
IUPHAR/BPS guide to pharmacology CITEno. 1 (2023)
引用0浏览0引用
0
0
Pharmacology research & perspectivesno. 4 (2021): e00799-e00799
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn